$MYGN
MYRIAD GENETICS INC Stock $mygn

$mygn Overview Financials Valuation SEC Filings Company Website

2024 Q4 Form 10-Q Financial Statement

#000089992324000057 Filed on November 08, 2024

Income Statement

Concept	2024 Q4	2024 Q3
Revenue		$213.3M
YoY Change		11.15%
Cost Of Revenue		$63.50M
YoY Change		10.24%
Gross Profit		$149.8M
YoY Change		11.54%
Gross Profit Margin		70.23%
Selling, General & Admin		$139.1M
YoY Change		2.2%
% of Gross Profit		92.86%
Research & Development		$28.50M
YoY Change		18.75%
% of Gross Profit		19.03%
Depreciation & Amortization		$4.800M
YoY Change		41.18%
% of Gross Profit		3.2%
Operating Expenses		$167.6M
YoY Change		4.68%
Operating Profit		-$20.00M
YoY Change		-66.72%
Interest Expense		-$400.0K
YoY Change		-140.0%
% of Operating Profit
Other Income/Expense, Net		-$1.200M
YoY Change		9.09%
Pretax Income		-$21.20M
YoY Change		-65.36%
Income Tax		$900.0K
% Of Pretax Income
Net Earnings		-$22.10M
YoY Change		-63.95%
Net Earnings / Revenue		-10.36%
Basic Earnings Per Share		-$0.24
Diluted Earnings Per Share		-$0.24
COMMON SHARES
Basic Shares Outstanding	91.04M shares	90.82M shares
Diluted Shares Outstanding		90.90M shares

Balance Sheet

Concept	2024 Q4	2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents		$99.90M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory		$26.20M
Prepaid Expenses
Receivables		$125.7M
Other Receivables
Total Short-Term Assets		$293.2M
YoY Change		10.47%
LONG-TERM ASSETS
Property, Plant & Equipment		$115.4M
YoY Change		-4.39%
Goodwill		$286.3M
YoY Change		-0.1%
Intangibles		$312.5M
YoY Change		-12.37%
Long-Term Investments
YoY Change
Other Assets		$16.50M
YoY Change		4.43%
Total Long-Term Assets		$788.1M
YoY Change		-10.82%
TOTAL ASSETS
Total Short-Term Assets		$293.2M
Total Long-Term Assets		$788.1M
Total Assets		$1.081B
YoY Change		-5.9%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable		$29.60M
YoY Change		-12.68%
Accrued Expenses		$111.2M
YoY Change		-29.44%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities		$154.3M
YoY Change		-26.28%
LONG-TERM LIABILITIES
Long-Term Debt		$39.00M
YoY Change		1.3%
Other Long-Term Liabilities		$34.30M
YoY Change		-15.31%
Total Long-Term Liabilities		$73.30M
YoY Change		-7.22%
TOTAL LIABILITIES
Total Short-Term Liabilities		$154.3M
Total Long-Term Liabilities		$73.30M
Total Liabilities		$349.6M
YoY Change		-24.93%
SHAREHOLDERS EQUITY
Retained Earnings		-$714.3M
YoY Change		19.39%
Common Stock		$1.446B
YoY Change		12.36%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity		$731.7M
YoY Change
Total Liabilities & Shareholders Equity		$1.081B
YoY Change		-5.9%

Cashflow Statement

Concept	2024 Q4	2024 Q3
OPERATING ACTIVITIES
Net Income		-$22.10M
YoY Change		-63.95%
Depreciation, Depletion And Amortization		$4.800M
YoY Change		41.18%
Cash From Operating Activities		$3.000M
YoY Change		-113.57%
INVESTING ACTIVITIES
Capital Expenditures		$6.300M
YoY Change		-64.0%
Acquisitions
YoY Change
Other Investing Activities		$13.80M
YoY Change		-8.0%
Cash From Investing Activities		$7.500M
YoY Change		-400.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		-3.100M
YoY Change		24.0%
NET CHANGE
Cash From Operating Activities		3.000M
Cash From Investing Activities		7.500M
Cash From Financing Activities		-3.100M
Net Change In Cash		7.400M
YoY Change		-127.31%
FREE CASH FLOW
Cash From Operating Activities		$3.000M
Capital Expenditures		$6.300M
Free Cash Flow		-$3.300M
YoY Change		-91.67%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Entity Central Index Key EntityCentralIndexKey	0000899923
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	87-0494517
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	84116
	dei	City Area Code CityAreaCode	801
	dei	Local Phone Number LocalPhoneNumber	584-3600
	dei	Security12b Title Security12bTitle	Common Stock, $0.01 par value
	dei	Trading Symbol TradingSymbol	MYGN
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	91035230	shares
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	99900000	usd
CY2024Q3	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	0	usd
CY2023Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	8800000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	114300000	usd
CY2024Q3	us-gaap	Inventory Net InventoryNet	26200000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	22000000.0	usd
CY2024Q3	us-gaap	Prepaid Taxes PrepaidTaxes	17000000.0	usd
CY2023Q4	us-gaap	Prepaid Taxes PrepaidTaxes	17000000.0	usd
CY2024Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	24400000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	19400000	usd
CY2024Q3	us-gaap	Assets Current AssetsCurrent	293200000	usd
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	90500000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	90500000	shares
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-36700000	usd
	dei	Entity Address City Or Town EntityAddressCityOrTown	Salt Lake City
	dei	Entity Address State Or Province EntityAddressStateOrProvince	UT
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.94
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.94
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	81600000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	81600000	shares
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-15300000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-56200000	usd
	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	15400000	usd
	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	53200000	usd
	us-gaap	Payments For Software PaymentsForSoftware	8400000	usd
	us-gaap	Payments For Software PaymentsForSoftware	6600000	usd
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	9000000.0	usd
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	103700000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-6000000.0	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	43900000	usd
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	3000000.0	usd
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	0	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	12200000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	7300000	usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	100000000.0	usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	40000000.0	usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	100000000.0	usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	0	usd
	us-gaap	Payments Of Debt Restructuring Costs PaymentsOfDebtRestructuringCosts	0	usd
	us-gaap	Payments Of Debt Restructuring Costs PaymentsOfDebtRestructuringCosts	1600000	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	300000	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	100000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-9500000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	31000000.0	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-300000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-100000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-31100000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	18600000	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	109800000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	85000000.0	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-84400000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-229900000	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	100000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	400000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2200000	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-22100000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-61300000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-84800000	usd
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.24
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	81900000	shares
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-61300000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	66400000	usd
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reclassifications</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain prior period amounts have been reclassified to conform with the current period presentation. The reclassifications have no impact on the Company's total assets, total liabilities, stockholders' equity, or cash flows from operations.</span></div>
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	us-gaap	Revenue From Contract With Customer Product And Service Extensible List RevenueFromContractWithCustomerProductAndServiceExtensibleList	http://www.myriad.com/20240930#TestingMember
CY2023Q3	us-gaap	Revenue From Contract With Customer Product And Service Extensible List RevenueFromContractWithCustomerProductAndServiceExtensibleList	http://www.myriad.com/20240930#TestingMember
	dei	Document Period End Date DocumentPeriodEndDate	2024-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity Registrant Name EntityRegistrantName	MYRIAD GENETICS, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Address Address Line1 EntityAddressAddressLine1	322 North 2200 West
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	132100000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	313600000	usd
CY2024Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	57400000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	61600000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	119000000.0	usd
CY2024Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	312500000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	349500000	usd
CY2024Q3	us-gaap	Goodwill Goodwill	286300000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	287400000	usd
CY2024Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	16500000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	15400000	usd
CY2024Q3	us-gaap	Assets Assets	1081300000	usd
CY2023Q4	us-gaap	Assets Assets	1146500000	usd
CY2024Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	29600000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	25800000	usd
CY2024Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	111200000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	113900000	usd
CY2024Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	13500000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	16200000	usd
CY2024Q3	us-gaap	Liabilities Current LiabilitiesCurrent	154300000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	155900000	usd
CY2024Q3	mygn	Unrecognized Tax Benefits Net UnrecognizedTaxBenefitsNet	31400000	usd
CY2023Q4	mygn	Unrecognized Tax Benefits Net UnrecognizedTaxBenefitsNet	30200000	usd
CY2024Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	39000000.0	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	38500000	usd
CY2024Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	90600000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	97400000	usd
CY2024Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	34300000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	41300000	usd
CY2024Q3	us-gaap	Liabilities Liabilities	349600000	usd
CY2024Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	91000000.0	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	89900000	shares
CY2024Q3	us-gaap	Common Stock Value CommonStockValue	900000	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	900000	usd
CY2024Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1445200000	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1415500000	usd
CY2024Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-100000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-3700000	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-714300000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-629500000	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	731700000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	783200000	usd
CY2024Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1081300000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1146500000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-61300000	usd
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.84
	us-gaap	Revenue From Contract With Customer Product And Service Extensible List RevenueFromContractWithCustomerProductAndServiceExtensibleList	http://www.myriad.com/20240930#TestingMember
CY2024Q3	us-gaap	Revenue From Contract With Customer Product And Service Extensible List RevenueFromContractWithCustomerProductAndServiceExtensibleList	http://www.myriad.com/20240930#TestingMember
	us-gaap	Type Of Cost Good Or Service Extensible List TypeOfCostGoodOrServiceExtensibleList	http://www.myriad.com/20240930#TestingMember
	us-gaap	Type Of Cost Good Or Service Extensible List TypeOfCostGoodOrServiceExtensibleList	http://www.myriad.com/20240930#TestingMember
CY2024Q3	us-gaap	Type Of Cost Good Or Service Extensible List TypeOfCostGoodOrServiceExtensibleList	http://www.myriad.com/20240930#TestingMember
CY2023Q3	us-gaap	Type Of Cost Good Or Service Extensible List TypeOfCostGoodOrServiceExtensibleList	http://www.myriad.com/20240930#TestingMember
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2024Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	125700000	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	115400000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	363300000	usd
CY2024Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	213300000	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	191900000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	627000000.0	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	556600000	usd
CY2024Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	63500000	usd
CY2023Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	57600000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	192500000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	174600000	usd
CY2024Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	28500000	usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	24000000.0	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	81200000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	67700000	usd
CY2024Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	139100000	usd
CY2023Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	136100000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	424000000.0	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	428500000	usd
CY2024Q3	us-gaap	Legal Fees LegalFees	0	usd
CY2023Q3	us-gaap	Legal Fees LegalFees	34300000	usd
	us-gaap	Legal Fees LegalFees	0	usd
	us-gaap	Legal Fees LegalFees	111800000	usd
CY2024Q3	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	2200000	usd
CY2023Q3	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0	usd
	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	13800000	usd
	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0	usd
CY2024Q3	us-gaap	Costs And Expenses CostsAndExpenses	233300000	usd
CY2023Q3	us-gaap	Costs And Expenses CostsAndExpenses	252000000.0	usd
	us-gaap	Costs And Expenses CostsAndExpenses	711500000	usd
	us-gaap	Costs And Expenses CostsAndExpenses	782600000	usd
CY2024Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-20000000.0	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-60100000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-84500000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-226000000.0	usd
CY2024Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	400000	usd
CY2023Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	600000	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	1400000	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	1800000	usd
CY2024Q3	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	800000	usd
CY2023Q3	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	1000000.0	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	2100000	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	2000000.0	usd
CY2024Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-800000	usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-700000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	800000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-3700000	usd
CY2024Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1200000	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1100000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	100000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-3900000	usd
CY2024Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-21200000	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-61200000	usd
CY2024Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	900000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-232100000	usd
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.24
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.75
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.75
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.84
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	90900000	shares
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	90900000	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	81900000	shares
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-22100000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-84800000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-232100000	usd
CY2024Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	0	usd
CY2023Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	300000	usd
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	100000	usd
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	2500000	usd
CY2024Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-500000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-100000	usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-1500000	usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	700000	usd
CY2024Q3	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	0	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	-100000	usd
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	0	usd
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	-1500000	usd
CY2024Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment From Aoci Realized Upon Sale Or Liquidation Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax	-4400000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment From Aoci Realized Upon Sale Or Liquidation Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax	100000	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment From Aoci Realized Upon Sale Or Liquidation Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax	-5100000	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment From Aoci Realized Upon Sale Or Liquidation Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax	-400000	usd
CY2024Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-18200000	usd
CY2023Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-61100000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-81100000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-227000000.0	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	885800000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	-4900000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	7500000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-54700000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	1500000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	835200000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	2900000	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	11200000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-116100000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	2000000.0	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	735200000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	-2200000	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	11600000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	100000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	683400000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	783200000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	-8700000	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	12000000.0	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-26000000.0	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-500000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	760000000.0	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	2500000	usd
CY2024Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	14500000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	200000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	740500000	usd
CY2024Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	-3000000.0	usd
CY2024Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	12400000	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-22100000	usd
CY2024Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	3900000	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	731700000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-84800000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-232100000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	46400000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	46800000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	6700000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	8600000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	38900000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	30300000	usd
	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-3000000.0	usd
	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-1700000	usd
	mygn	Increase Decrease In Unrecognized Tax Benefits IncreaseDecreaseInUnrecognizedTaxBenefits	1200000	usd
	mygn	Increase Decrease In Unrecognized Tax Benefits IncreaseDecreaseInUnrecognizedTaxBenefits	2800000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-800000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	usd
	us-gaap	Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments	0	usd
	us-gaap	Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments	-1500000	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	13600000	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	3100000	usd
	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	0	usd
	mygn	Asset Acquisition Gain Loss AssetAcquisitionGainLoss	2200000	usd
	mygn	Asset Acquisition Gain Loss AssetAcquisitionGainLoss	0	usd
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	2000000.0	usd
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	3000000.0	usd
	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	4600000	usd
	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	1800000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	12700000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	13700000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	4900000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	5000000.0	usd
	us-gaap	Increase Decrease In Prepaid Taxes IncreaseDecreaseInPrepaidTaxes	100000	usd
	us-gaap	Increase Decrease In Prepaid Taxes IncreaseDecreaseInPrepaidTaxes	-200000	usd
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	200000	usd
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	200000	usd
	us-gaap	Payments For Proceeds From Tenant Allowance PaymentsForProceedsFromTenantAllowance	0	usd
	us-gaap	Payments For Proceeds From Tenant Allowance PaymentsForProceedsFromTenantAllowance	-16300000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	5800000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2200000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-13500000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	86600000	usd
	us-gaap	Proceeds From Divestiture Of Businesses Net Of Cash Divested ProceedsFromDivestitureOfBusinessesNetOfCashDivested	8800000	usd
	us-gaap	Proceeds From Divestiture Of Businesses Net Of Cash Divested ProceedsFromDivestitureOfBusinessesNetOfCashDivested	0	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	140900000	usd
CY2024Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	213300000	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	191900000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	627000000.0	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	556600000	usd
CY2024Q3	us-gaap	Contract With Customer Asset Cumulative Catch Up Adjustment To Revenue Change In Estimate Of Transaction Price ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice	8600000	usd
	us-gaap	Contract With Customer Asset Cumulative Catch Up Adjustment To Revenue Change In Estimate Of Transaction Price ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice	17300000	usd
CY2024Q3	mygn	Increase Decrease In Earnings Loss Per Share IncreaseDecreaseInEarningsLossPerShare	0.09
	mygn	Increase Decrease In Earnings Loss Per Share IncreaseDecreaseInEarningsLossPerShare	0.19
	us-gaap	Contract With Customer Asset Cumulative Catch Up Adjustment To Revenue Modification Of Contract ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueModificationOfContract	3000000.0	usd
CY2023Q3	us-gaap	Contract With Customer Asset Cumulative Catch Up Adjustment To Revenue Change In Estimate Of Transaction Price ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice	7100000	usd
	us-gaap	Contract With Customer Asset Cumulative Catch Up Adjustment To Revenue Change In Estimate Of Transaction Price ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice	6200000	usd
CY2023Q3	mygn	Increase Decrease In Earnings Loss Per Share IncreaseDecreaseInEarningsLossPerShare	0.07
	mygn	Increase Decrease In Earnings Loss Per Share IncreaseDecreaseInEarningsLossPerShare	0.06
CY2024Q3	us-gaap	Capitalized Contract Cost Gross CapitalizedContractCostGross	0	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risk</span></div>Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents and accounts receivable. The Company limits its exposure to loss by placing its cash in financial institutions with high credit ratings. The Company's cash may consist of deposits held with banks that may at times exceed federally insured limits of $250,000 per customer. Substantially all of the Company’s accounts receivable are with companies in the healthcare industry, U.S. and state governmental agencies, and individuals. The Company does not believe that receivables due from U.S. and state governmental agencies, such as Medicare, represent a credit risk since the related healthcare programs are funded by the U.S. and state governments.
CY2024Q3	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	0	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	132100000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	132100000	usd
CY2023Q4	mygn	Investments And Cash Amortized Cost InvestmentsAndCashAmortizedCost	141000000.0	usd
CY2023Q4	mygn	Investments And Cash Accumulated Gross Unrealized Gain Before Tax InvestmentsAndCashAccumulatedGrossUnrealizedGainBeforeTax	0	usd
CY2023Q4	mygn	Investments And Cash Accumulated Gross Unrealized Loss Before Tax InvestmentsAndCashAccumulatedGrossUnrealizedLossBeforeTax	100000	usd
CY2023Q4	us-gaap	Investments And Cash InvestmentsAndCash	140900000	usd
CY2024Q3	us-gaap	Fair Value Net Asset Liability FairValueNetAssetLiability	0	usd
CY2023Q4	us-gaap	Fair Value Net Asset Liability FairValueNetAssetLiability	5600000	usd
CY2023Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	5400000	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	500000	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements	5800000	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Other Comprehensive Income FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome	-100000	usd
CY2024Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	0	usd
CY2024Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	232700000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	238900000	usd
CY2024Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	117300000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	119900000	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	115400000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	119000000.0	usd
CY2024Q3	us-gaap	Depreciation Depreciation	4800000	usd
CY2023Q3	us-gaap	Depreciation Depreciation	3400000	usd
	us-gaap	Depreciation Depreciation	14500000	usd
	us-gaap	Depreciation Depreciation	14800000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	287400000	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	800000	usd
	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-300000	usd
CY2024Q3	us-gaap	Goodwill Goodwill	286300000	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	800000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	631400000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	318900000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	312500000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	645800000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	296300000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	349500000	usd
CY2024Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	10500000	usd
CY2023Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	10700000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	31900000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	32000000.0	usd
CY2024Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	51400000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	49700000	usd
CY2024Q3	us-gaap	Taxes Payable Current TaxesPayableCurrent	4200000	usd
CY2023Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	4600000	usd
CY2024Q3	mygn	Refunds Payable And Reserve Current RefundsPayableAndReserveCurrent	19200000	usd
CY2023Q4	mygn	Refunds Payable And Reserve Current RefundsPayableAndReserveCurrent	20100000	usd
CY2024Q3	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	0	usd
CY2023Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	3100000	usd
CY2024Q3	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	6600000	usd
CY2023Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	5300000	usd
CY2024Q3	us-gaap	Litigation Reserve Current LitigationReserveCurrent	6000000.0	usd
CY2023Q4	us-gaap	Litigation Reserve Current LitigationReserveCurrent	6000000.0	usd
CY2024Q3	mygn	Lease Termination Accrual Current LeaseTerminationAccrualCurrent	4300000	usd
CY2023Q4	mygn	Lease Termination Accrual Current LeaseTerminationAccrualCurrent	4400000	usd
CY2024Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	19500000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	20700000	usd
CY2024Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	111200000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	113900000	usd
CY2024Q3	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	0	usd
CY2023Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	2300000	usd
CY2024Q3	mygn	Escrow Liability Noncurrent EscrowLiabilityNoncurrent	7500000	usd
CY2023Q4	mygn	Escrow Liability Noncurrent EscrowLiabilityNoncurrent	7500000	usd
CY2024Q3	mygn	Legal Charges Pending Settlement Noncurrent LegalChargesPendingSettlementNoncurrent	24000000.0	usd
CY2023Q4	mygn	Legal Charges Pending Settlement Noncurrent LegalChargesPendingSettlementNoncurrent	24000000.0	usd
CY2024Q3	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	2800000	usd
CY2023Q4	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	7500000	usd
CY2024Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	34300000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	41300000	usd
CY2024Q3	mygn	Legal Charges Pending Settlement Noncurrent LegalChargesPendingSettlementNoncurrent	24000000	usd
CY2024Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000.0	shares
CY2024Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2024Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000.0	shares
CY2024Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2024Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	91000000.0	shares
CY2024Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	91000000.0	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	89900000	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	89900000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	81200000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	81200000	shares
	mygn	Stock Issued During Period Shares Share Based Payment Arrangement And Employee Stock Purchase Plans StockIssuedDuringPeriodSharesShareBasedPaymentArrangementAndEmployeeStockPurchasePlans	1100000	shares
	mygn	Stock Issued During Period Shares Share Based Payment Arrangement And Employee Stock Purchase Plans StockIssuedDuringPeriodSharesShareBasedPaymentArrangementAndEmployeeStockPurchasePlans	900000	shares
CY2024Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	91000000.0	shares
CY2024Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	91000000.0	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	82100000	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	82100000	shares
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	90900000	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	81900000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	90500000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	81600000	shares
CY2024Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2023Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	90900000	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	81900000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	90500000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	81600000	shares
CY2024Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5900000	shares
CY2023Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5300000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5900000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5300000	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	700000	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	13.38
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	700000	shares
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	13.38
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	500000	shares
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	13.38
CY2024Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	0	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2024Q3	us-gaap	Share Based Compensation ShareBasedCompensation	12400000	usd
CY2023Q3	us-gaap	Share Based Compensation ShareBasedCompensation	11600000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	38900000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	30300000	usd
CY2024Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	900000	usd
CY2024Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.042
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	100000	usd
CY2023Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.002
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	400000	usd
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.005
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2200000	usd
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.010
	us-gaap	Income Taxes Paid IncomeTaxesPaid	1800000	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	1300000	usd
	us-gaap	Interest Paid Net InterestPaidNet	1300000	usd
	us-gaap	Interest Paid Net InterestPaidNet	800000	usd
	mygn	Change In Operating Lease Right Of Use Asset ChangeInOperatingLeaseRightOfUseAsset	-300000	usd
	mygn	Change In Operating Lease Right Of Use Asset ChangeInOperatingLeaseRightOfUseAsset	8700000	usd
	mygn	Change In Operating Lease Liability ChangeInOperatingLeaseLiability	-3100000	usd
	mygn	Change In Operating Lease Liability ChangeInOperatingLeaseLiability	9200000	usd
	mygn	Non Cash Adjustment To Right Of Use Assets And Lease Liabilities From Lease Modifications NonCashAdjustmentToRightOfUseAssetsAndLeaseLiabilitiesFromLeaseModifications	3100000	usd
	mygn	Non Cash Adjustment To Right Of Use Assets And Lease Liabilities From Lease Modifications NonCashAdjustmentToRightOfUseAssetsAndLeaseLiabilitiesFromLeaseModifications	0	usd
	mygn	Purchases Of Property Plant And Equipment And Capitalization Of Internal Use Software In Accounts Payable And Accrued Liabilities PurchasesOfPropertyPlantAndEquipmentAndCapitalizationOfInternalUseSoftwareInAccountsPayableAndAccruedLiabilities	2500000	usd
	mygn	Purchases Of Property Plant And Equipment And Capitalization Of Internal Use Software In Accounts Payable And Accrued Liabilities PurchasesOfPropertyPlantAndEquipmentAndCapitalizationOfInternalUseSoftwareInAccountsPayableAndAccruedLiabilities	9100000	usd
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	99900000	usd
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	76000000.0	usd
CY2024Q3	us-gaap	Restricted Cash RestrictedCash	9900000	usd
CY2023Q3	us-gaap	Restricted Cash RestrictedCash	9000000.0	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	109800000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	85000000.0	usd
	mygn	Operating Lease Liability Current Terminated OperatingLeaseLiabilityCurrentTerminated	3100000	usd
	mygn	Asset Acquisition Gain Loss AssetAcquisitionGainLoss	2200000	usd
CY2024Q3	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q3	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q3	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q3	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
0000899923-24-000057-index-headers.html	Edgar Link	pending
0000899923-24-000057-index.html	Edgar Link	pending
0000899923-24-000057.txt	Edgar Link	pending
0000899923-24-000057-xbrl.zip	Edgar Link	pending
exhibit311-certificationof.htm	Edgar Link	pending
exhibit312-certificationof.htm	Edgar Link	pending
exhibit321-certificationpu.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
mygn-20240930.htm	Edgar Link	pending
mygn-20240930.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
mygn-20240930_cal.xml	Edgar Link	unprocessable
mygn-20240930_def.xml	Edgar Link	unprocessable
mygn-20240930_lab.xml	Edgar Link	unprocessable
mygn-20240930_pre.xml	Edgar Link	unprocessable
mygn-20240930_htm.xml	Edgar Link	completed
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MYGN
MYRIAD GENETICS INC Stock $mygn

2024 Q4 Form 10-Q Financial Statement

#000089992324000057 Filed on November 08, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MYGN MYRIAD GENETICS INC Stock $mygn

2024 Q4 Form 10-Q Financial Statement

#000089992324000057 Filed on November 08, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MYGN
MYRIAD GENETICS INC Stock $mygn